KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Current Liabilities: 2009-2024

Historic Total Current Liabilities for Idexx Laboratories (IDXX) over the last 16 years, with Dec 2024 value amounting to $1.1 billion.

  • Idexx Laboratories' Total Current Liabilities rose 24.04% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 24.04%. This contributed to the annual value of $1.1 billion for FY2024, which is 12.23% up from last year.
  • Latest data reveals that Idexx Laboratories reported Total Current Liabilities of $1.1 billion as of FY2024, which was up 12.23% from $951.5 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Total Current Liabilities peaked at $1.2 billion during FY2022, and registered a low of $582.8 million during FY2020.
  • Moreover, its 3-year median value for Total Current Liabilities was $1.1 billion (2024), whereas its average is $1.1 billion.
  • Per our database at Business Quant, Idexx Laboratories' Total Current Liabilities skyrocketed by 61.84% in 2022 and then fell by 23.00% in 2023.
  • Over the past 5 years, Idexx Laboratories' Total Current Liabilities (Yearly) stood at $582.8 million in 2020, then surged by 31.03% to $763.6 million in 2021, then skyrocketed by 61.84% to $1.2 billion in 2022, then declined by 23.00% to $951.5 million in 2023, then increased by 12.23% to $1.1 billion in 2024.